Skip to main content

STANDEX INTERNATIONAL CORP/DE/

For the period ended Dec 31, 2025. Filed Feb 2, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2025 · Filed Feb 2, 2026

SXI$228.36-1.9%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Item 1. Unaudited Condensed Consolidated Balance Sheets

(In thousands, except share and per share data)December 31, 2025June 30, 2025
ASSETS
Current assets:
Cash and cash equivalents$96,998$104,542
Accounts receivable, less allowance for credit losses of $4,051 and $3,985 at December 31, 2025 and June 30, 2025, respectively176,628172,702
Inventories131,196129,994
Contract assets62,87459,228
Prepaid expenses and other current assets23,03814,413
Total current assets490,734480,879
Property, plant, and equipment, net160,378160,364
Intangible assets, net212,052225,757
Goodwill594,080610,338
Deferred tax asset11,68711,971
Operating lease right-of-use asset47,83547,998
Other non-current assets37,73529,573
Total non-current assets1,063,7671,086,001
Total assets$1,554,501$1,566,880
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable$87,773$88,001
Accrued liabilities69,40363,204
Income taxes payable13,63315,770
Total current liabilities170,809166,975
Long-term debt534,733552,515
Operating lease long-term liabilities37,99740,057
Accrued pension and other non-current liabilities66,21567,743
Total non-current liabilities638,945660,315
Contingencies (Note 15)
Redeemable noncontrolling interest44,51127,913
Stockholders' equity:
Common stock, par value $1.50 per share, 60,000,000 shares authorized, 27,984,278 shares issued, 12,047,561 and 11,992,116 shares outstanding at December 31, 2025 and June 30, 202541,97641,976
Additional paid-in capital140,476136,082
Retained earnings1,136,0961,126,851
Accumulated other comprehensive loss(188,019)(164,765)
Treasury shares: 15,936,717 and 15,992,162 shares at December 31, 2025 and June 30, 2025(430,293)(428,467)
Total stockholders' equity700,236711,677
Total liabilities and stockholders' equity$1,554,501$1,566,880

Unaudited Condensed Consolidated Statements of Operations

Three Months Ended December 31,Six Months Ended December 31,
(In thousands, except per share data)2025202420252024
Net sales$221,320$189,814$438,751$360,278
Cost of sales129,087118,367256,086218,758
Gross profit92,23371,447182,665141,520
Selling, general, and administrative expenses55,60545,664109,97488,712
Restructuring costs4389206,4362,006
Acquisition related costs61716,4001,04918,240
Total operating expenses56,66062,984117,459108,958
Income from operations35,5738,46365,20632,562
Interest expense7,9145,57516,8266,552
Other non-operating expense, net490890225862
Income from continuing operations before income taxes27,1691,99848,15525,148
Provision for income taxes6,53671011,7015,672
Income from continuing operations20,6331,28836,45419,476
Income (Loss) from discontinued operations, net of tax48(13)21(4)
Net income20,6811,27536,47519,472
Less: net income attributable to redeemable noncontrolling interest18,56141819,300418
Net income attributable to common stockholders2,12085717,17519,054
Basic earnings per share attributable to Standex International Corporation shareholders:
Continuing operations0.170.071.43$1.60
Discontinued operations0.00-0.00-
Total0.17$0.07$1.43$1.60
Diluted earnings per share attributable to Standex International Corporation shareholders:
Continuing operations0.170.071.42$1.59
Discontinued operations0.00-0.00-
Total0.17$0.07$1.42$1.59
Weighted average number of shares:
Basic12,04311,94212,02711,872
Diluted12,05512,02512,07311,972

Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)

Three Months Ended December 31,Six Months Ended December 31,
(In thousands)2025202420252024
Net income$20,681$1,275$36,475$19,472
Other comprehensive income (loss):
Defined benefit pension plans:
Actuarial (losses) gains and other changes in unrecognized costs, net of tax(22)266$57$48
Amortization of unrecognized costs, net of tax8987981,7971,597
Derivative instruments:
Change in unrealized gains (losses), net of tax195137(588)(154)
Amortization of unrealized losses into interest expense, net of tax(227)(1,101)(346)(2,385)
Foreign currency translation losses, net of tax(10,004)(27,447)(25,278)(4,436)
Other comprehensive loss(9,160)(27,347)(24,358)(5,330)
Total comprehensive income (loss)11,521(26,072)12,11714,142
Less: comprehensive income (loss) attributable to redeemable noncontrolling interest18,235(99)18,196(99)
Total comprehensive income (loss) attributable to Standex International Corporation$(6,714)$(25,973)$(6,079)$14,241

Unaudited Condensed Consolidated Statements of Stockholders' Equity

For the three month period ended · Redeemable · Additional · Accumulated Other · Total
December 31, 2025 · Noncontrolling · Common · Paid-in · Retained · Comprehensive · Treasury Stock · Stockholders'
(in thousands, except as specified)InterestStockCapitalEarningsIncome (Loss)SharesAmountEquity
Balance, September 30, 2025$27,149$41,976$137,415$1,138,071$(179,185)15,951$(430,618)$707,659
Stock issued under incentive compensation plans and employee purchase plans and business acquisitions--(4)--(14)391387
Stock-based compensation--3,065----3,065
Treasury stock acquired------(66)(66)
Comprehensive income:--------
Net income18,561--2,120---2,120
Foreign currency translation adjustment(326)---(9,678)--(9,678)
Pension, net of tax of $0.3 million----876--876
Change in fair value of derivatives, net of tax of $0.0 million----(32)--(32)
Distributions to noncontrolling interests(873)-------
Dividends declared ($0.34 per share)---(4,095)---(4,095)
Balance, December 31, 2025$44,511$41,976$140,476$1,136,096$(188,019)15,937$(430,293)$700,236
For the three month period ended December 31, 2024 · Redeemable · Additional · Accumulated Other · Total
Noncontrolling · Common · Paid-in · Retained · Comprehensive · Treasury Stock · Stockholders'
(in thousands, except as specified) · Interest · Stock · Capital · Earnings · Income (Loss) · Shares · Amount · Equity
Balance, September 30, 2024$-$41,976$108,383$1,100,924$(160,939)16,171$(432,323)$658,021
Stock issued under incentive compensation plans and employee purchase plans--(525)--(25)679154
Stock issued for business acquisition21,882--(152)4,07125,953
Fair value of noncontrolling interest at acquisition26,734---
Stock-based compensation--2,587----2,587
Treasury stock acquired---4(784)(784)
Comprehensive income:
Net income418--857---857
Foreign currency translation adjustment(517)---(26,930)--(26,930)
Pension, net of tax of $0.3 million----1,064--1,064
Change in fair value of derivatives, net of tax of $0.3 million----(964)--(964)
Dividends declared ($0.32 per share)---(3,924)---(3,924)
Balance, December 31, 2024$26,635$41,976$132,327$1,097,857$(187,769)15,998$(428,357)$656,034

Unaudited Condensed Consolidated Statements of Stockholders' Equity

For the six month period ended · Redeemable · Additional · Accumulated Other · Total
December 31, 2025 · Noncontrolling · Common · Paid-in · Retained · Comprehensive · Treasury Stock · Stockholders'
(in thousands, except as specified)InterestStockCapitalEarningsIncome (Loss)SharesAmountEquity
Balance, June 30, 2025$27,913$41,976$136,082$1,126,851$(164,765)15,992$(428,467)$711,677
Stock issued under incentive compensation plans and employee purchase plans--(444)--(73)1,9721,528
Stock-based compensation--4,838----4,838
Treasury stock acquired-----18(3,798)(3,798)
Comprehensive income:-----
Net Income19,300--17,175---17,175
Foreign currency translation adjustment(1,104)---(24,174)--(24,174)
Pension, net of tax of $0.6 million----1,854--1,854
Change in fair value of derivatives, net of tax of $0.3 million----(934)--(934)
Distributions to noncontrolling interests(1,598)-------
Dividends declared ($0.66 per share)---(7,930)---(7,930)
Balance, December 31, 2025$44,511$41,976$140,476$1,136,096$(188,019)15,937$(430,293)$700,236
For the six month period ended December 31, 2024 · Redeemable · Additional · Accumulated Other · Total
Noncontrolling · Common · Paid-in · Retained · Comprehensive · Treasury Stock · Stockholders'
(in thousands, except as specified) · Interest · Stock · Capital · Earnings · Income (Loss) · Shares · Amount · Equity
Balance, June 30, 2024$-$41,976$106,193$1,086,277$(182,956)16,222$(429,987)$621,503
Stock issued under incentive compensation plans and employee purchase plans--(903)--(101)2,6931,790
Stock issued for business acquisition--21,882--(152)4,07125,953
Fair value of noncontrolling interest at acquisition26,734-------
Stock-based compensation--5,155----5,155
Treasury stock acquired-----29(5,134)(5,134)
Comprehensive income:
Net income418--19,054---19,054
Foreign currency translation adjustment(517)---(3,919)--(3,919)
Pension, net of tax of $0.5 million----1,645--1,645
Change in fair value of derivatives, net of tax of $0.8 million----(2,539)--(2,539)
Dividends declared ($0.62 per share)---(7,474)---(7,474)
Balance, December 31, 2024$26,635$41,976$132,327$1,097,857$(187,769)15,998$(428,357)$656,034

** Unaudited Condensed Consolidated Statements of Cash Flows**

Six Months Ended December 31,
(In thousands) · 2025 · 2024
Cash flows from operating activities
Net income$36,475$19,472
Income (loss) from discontinued operations21(4)
Income from continuing operations36,45419,476
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization19,80115,566
Stock-based compensation4,8385,155
Non-cash portion of restructuring charge149(896)
Contributions to defined benefit plans(2,796)(4,766)
Changes in operating assets and liabilities, net(20,935)(7,873)
Net cash provided by operating activities - continuing operations37,51126,662
Net cash used in operating activities - discontinued operations(127)(31)
Net cash provided by operating activities37,38426,631
Cash flows from investing activities
Expenditures for property, plant, and equipment(14,084)(13,690)
Expenditures for acquisitions, net of cash acquired-(419,652)
Other investing activity(5)3,904
Net cash used in investing activities(14,089)(429,438)
Cash flows from financing activities
Proceeds from borrowings8,000724,313
Payments of debt(26,000)(339,110)
Contingent consideration payment(330)-
Activity under share-based payment plans1,5281,792
Purchases of treasury stock and other(3,798)(9,582)
Distributions to non-controlling interests(1,598)-
Cash dividends paid(7,930)(7,362)
Net cash (used in) provided by financing activities(30,128)370,051
Effect of exchange rate changes on cash and cash equivalents(711)(300)
Net change in cash and cash equivalents(7,544)(33,056)
Cash and cash equivalents at beginning of year104,542154,203
Cash and cash equivalents at end of period$96,998$121,147
Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for:
Interest$16,627$3,555
Income taxes, net of refunds$15,946$6,245
Stock issued for business acquisition$-$25,953

S****TANDEX INTERNATIONAL CORPORATION

Notes to Unaudited** **Condensed Consolidated Financial Statements

1) Management Statement

Standex International Corporation (“Standex” or the “Company”) is a diversified industrial manufacturer infive broad business segments: Electronics, Engineering Technologies, Scientific, Engraving and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China. The accompanying consolidated financial statements include the accounts of Standex International Corporation and its subsidiaries and are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany accounts and transactions have been eliminated in consolidation. Noncontrolling interests in subsidiaries related to Standex’ ownership interests of less than100% are reported as Noncontrolling interests in the consolidated balance sheets. The results of noncontrolling ownership interests held by Standex are reported as Net income attributable to redeemable noncontrolling interests in the consolidated statements of operations.

The Company considers events or transactions that occur after the balance sheet date, but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company evaluated subsequent events through the date and time our consolidated financial statements were issued.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the results of operations for thethree andsix months ended* December 31, 2025and2024*, the cash flows for thesix months ended* December 31, 2025and2024* and the financial position of Standex International Corporation (“Standex”, the “Company”, “we”, “us”, or “our”), at* December 31, 2025*. The interim results arenot necessarily indicative of results for a full year. The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the informationnot misleading. The unaudited condensed consolidated financial statements and notes donot contain information which would substantially duplicate the disclosures contained in the audited annual consolidated financial statements and notes for the year ended* June 30, 2025*. The condensed consolidated balance sheet at* June 30, 2025* presented herein was derived from audited financial statements, but doesnot include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements contained herein should be read in conjunction with the Annual Report on Form10-K and in particular the audited consolidated financial statements for the year ended* June 30, 2025*. Unless otherwise noted, references to years are to the Company’s fiscal years. Currently the fiscal year end is* June 30.For further clarity, the Company's fiscal year2026* includes thetwelve-month period from* July 1, 2025to June 30, 2026.*

The preparation of consolidated financial statements in conformity with GAAP requires the use of estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of the financial statements and for the period then ended. Estimates are based on historical experience, actuarial estimates, current conditions and various other assumptions that are believed to be reasonable under the circumstances. These estimates form the basis for making judgments about the carrying values of assets and liabilities when they arenot readily apparent from other sources. These estimates assist in the identification and assessment of the accounting treatment necessary with respect to commitments and contingencies. Actual results* maydiffer from these estimates under different assumptions or conditions. The estimates and assumptions used in the preparation of the consolidated financial statements have considered the implications on the Company as a result of ongoing global events and related economic impacts. As a result, there is heightened volatility and uncertainty around tariff actions, supply chain performance, labor availability, and customer demand. However, the magnitude of such impact on the Company’s business and its duration is uncertain. The Company isnot* aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of* December 31, 2025* and the issuance date of the quarterly report on Form10-Q.

Research and development expenditures are expensed as incurred. Total research and development costs, which are classified under selling, general, and administrative expenses were $6.3 million and $5.3 million for thethree months ended* December 31, 2025* and2024, respectively. Total research and development costs were $12.5 million and $10.2 million for thesix months ended* December 31, 2025* and2024, respectively.

Recently Issued Accounting Pronouncements

The Organization for Economic Co-operation and Development (OECD) and theG20 Inclusive Framework on Base Erosion and Profit Shifting (the "Inclusive Framework") have put forth Pillar Two proposals that ensure a minimal level of taxation. Several countries in which the Company operates, including several European Union member states, have adopted domestic legislation to implement the Inclusive Framework's global corporate minimum tax rate offifteen percent. This legislation became effective for the Company beginning in the fiscal year2025. Based on the Company's analysis of Pillar Two provisions, these tax law changes didnot have a material impact on the Company's financial statements for the fiscal year2026.

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed below, the Company doesnot believe that the adoption of recently issued standards had or* may*have a material impact on its unaudited condensed consolidated financial statements or disclosures.

9

In* December 2023,the FASB issued ASU2023*-09, Income Taxes (Topic740) - Improvements to Income Tax Disclosures. This ASU is expected to enhance the transparency and decision usefulness of income tax disclosures by requiring public business entities on an annual basis to disclose specific categories in the rate reconciliation, additional information for reconciling items that meet a quantitative threshold, and certain information about income taxes paid. This ASU is effective for fiscal years beginning after* December 15, 2024.The amendments in this ASU are required to be applied on a prospective basis and retrospective adoption is permitted. Based on the Company's current analysis, the Company doesnot* expect these changes to have a material impact on the Company's financial statements.

In* November 2024,the FASB issued ASU2024*-03, Income Statement - Reporting Comprehensive Income (Topic220): Expense Disaggregation Disclosures. Additionally, in* January 2025,the FASB issued ASU2025*-01 to clarify the effective date of ASU2024-03. This ASU provides guidance to expand disclosures related to the disaggregation of income statement expenses. This ASU also requires, in the notes to the financial statements, disclosure of specified information about certain costs and expenses which includes purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each relevant expense caption. ASU2025-01 is effective for fiscal years beginning after* December 15, 2026,and interim periods within annual reporting periods beginning after December 15, 2027,on a retrospective or prospective basis, with early adoption permitted. This ASU will be effective for the Company’s Form10*-K for fiscal2028 and Form10-Q filed thereafter. The Company is currently evaluating the impact this ASU* may*have on its financial statement disclosures.

In* July 2025,the U.S. government enacted The One Big Beautiful Bill Act of2025* which includes, among other provisions, changes to the U.S. corporate income tax system including the allowance of immediate expensing of qualifying research and development expenses and permanent extensions of certain provisions within the Tax Cuts and Jobs Act. Certain provisions were effective for Standex beginning* June 1, 2025.Based on the Company's current analysis of the provisions, the Company doesnot* expect these tax law changes to have a material impact on the Company's financial statements. The Company will continue to evaluate the impact of these provisions throughout the remainder of the year.

In* July 2025,the FASB issued ASU2025*-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient for measuring expected credit losses on current trade receivables and contract assets by assuming that current conditions remain unchanged over the life of the asset. The amendments are effective for annual and interim periods beginning after* December 15, 2025,*with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In* September 2025,the FASB issued ASU2025*-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic350-40): Targeted Improvements to the Accounting for Internal-Use Software related to accounting for internal-use software costs. The amendments in this update improve the operability of the guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods. This update is effective for annual periods beginning after* December 15, 2027,*including interim periods within those fiscal years, though early adoption is permitted. The Company is currently in the process of evaluating the effects of this pronouncement on its consolidated financial statements.

In* November 2025,the FASB issued ASU2025*-09, Derivatives and Hedging (Topic815): Hedge Accounting Improvements. This ASU introducesfive targeted improvements to better align hedge accounting with entities’ risk management activities. This ASU is effective for fiscal years beginning after* December 15, 2026,and interim periods within those annual reporting periods, with early adoption permitted. The amendments in this ASU are required to be applied on a prospective basis for all hedging relationships. The Company is currently evaluating the impact this ASU may*have on its financial statement disclosures.

2) Acquisitions

McStarlite

On* February 5, 2025,*the Company acquired 100% of the issued and outstanding shares of Basmat Inc., dba McStarlite, a privately held company, for $57.0 million, net of cash acquired. McStarlite is a leading provider of complex sheet metal aerospace components. It designs and manufactures cold deep draw and bulge-formed aviation components, including segmented and single piece lipskins, nozzles, complex sheet metal assemblies, and tooling to support production hardware. McStarlite's results are reported within the Company's Engineering Technologies segment.

The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed based on a valuation of their fair values on the closing date. Goodwill recorded from this transaction is attributable to McStarlite's technical and applications expertise, which is highly complementary to the Company's existing business.

Identifiable intangible assets of $24.5 million consist primarily of $19.7 million for customer relationships to be amortized over 12 years and $4.8 million for indefinite lived tradenames. The goodwill of $16.2 million created by the transaction isnot deductible for income tax purposes. The accounting for business combinations requires estimates and judgments regarding expectations for future cash flows of the acquired business, and the allocations of those cash flows to identifiable tangible and intangible assets, in determining the assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's best estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques.

10

During thesix months ended* December 31, 2025*, the Company made the following changes to the purchase price allocation of McStarlite as mentioned below (in thousands):

Preliminary Allocation as of June 30, 2025 · Adjustments · Preliminary Allocation as of December 31, 2025
Total purchase consideration:
Cash payments$57,549$-$57,549
Less: cash acquired(586)-(586)
Total$56,963$-$56,963
Identifiable assets acquired and liabilities assumed:
Other acquired assets$8,808$-$8,808
Inventories6,744-6,744
Customer backlog3,970-3,970
Property, plant, and equipment8,603-8,603
Identifiable intangible assets24,500-24,500
Goodwill16,761(554)16,207
Liabilities assumed(12,423)554(11,869)
Total$56,963$-$56,963

There wereno changes to the purchase price allocations of any other acquisitions during thesix months ended* December 31, 2025*.

Amran/Narayan Group

On* October 28, 2024 (*“Closing Date”), the Company acquired, in separate transactions,100% of the outstanding membership interest in Amran LLC (“Amran”), a privately-held company based in Houston, Texas, pursuant to a Securities Purchase Agreement (the “Amran Purchase Agreement”) and through its wholly owned subsidiary, Mold-Tech Singapore PTE LTD (“Mold-Tech Singapore”),90.1% of the capital stock of Narayan Powertech Private Limited (“Narayan”), a privately-held India-based company, pursuant to a Securities Purchase Agreement (the “Narayan Purchase Agreement”) (collectively the “Amran/Narayan Group”). With manufacturing locations in the United States and India, Amran/Narayan Group is a leading manufacturer of low voltage and medium voltage instrument transformers. Its custom product portfolio is specifically designed and developed in partnership with OEMs for their specific equipment related to electrical grid applications. This acquisition continues the Company's portfolio strategy of focusing its higher-margin business segments in faster-growing markets. Amran/Narayan Group results are reported within the Company's Electronics segment.

Total consideration for Amran aggregated $179.7 million consisting of $153.7 million in cash consideration and 152,299 shares of Standex common stock, issued out of the Company's treasury shares, with a fair value of $26.0 million. The fair value of Standex common stock issued as part of the consideration for Amran was determined on the basis of the closing market price of our common shares on the Closing Date. The total consideration for the 90.1% interest in Narayan consisted of a cash payment of $261.9 million. The Company entered into a Shareholder Agreement that provides the Company with the right to purchase, and the noncontrolling interest holders with the right to sell, their remaining minority interest at a contractually defined redemption value. As the redemptions are contingently redeemable at the option of the noncontrolling interest shareholders, the Company classifies the redeemable noncontrolling interest in the mezzanine equity section on the consolidated balance sheets, which is presented above the equity section and below liabilities. The repurchase price of the redeemable noncontrolling interests is the greater of the share price paid for similar shares as part of the Amran/Narayan Acquisition or12 timestwelve months' trailing EBITDA. The redeemable noncontrolling interest represents the minority shareholder's interest. Subject to receipt of regulatory approval from the Reserve Bank of India (“RBI”), Mold-Tech Singapore will acquire the remaining 9.9% of the capital stock of Narayan in asecond closing for shares of Standex common stock with a fair value of $26.7 million ("Share Swap Provision").

Additionally, on* October 28, 2024,as contemplated by the Narayan Purchase Agreement, the Company, Mold-Tech Singapore and the owners of the remaining 9.9% ownership interest in Narayan, which wasnot* acquired by the Company, entered into a Shareholders’ Agreement. The Shareholders’ Agreement provides the noncontrolling interest holders with certain put rights upon the expiration of the Share Swap Provision. The noncontrolling interest holders will have the right (butnot an obligation) to transfer up to their remaining interest in Narayan for a period ofthree years ("Put Option Period") to Mold-Tech Singapore. Subsequent to the expiration of the Put Option Period, Mold-Tech Singapore will have the right (butnot an obligation) to acquire the remaining interest in Narayan for an additional three year consecutive period.

The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed and noncontrolling interest based on a valuation of their fair values on the Closing Date. Goodwill recorded from this transaction is attributable to Amran/Narayan Group’s technical and applications expertise, which is highly complementary to the Company's existing business.

Identifiable intangible assets of $136.0 million consist primarily of $28.7 million for indefinite lived tradenames and $107.3 million of customer relationships to be amortized over 12 years. Goodwill of $298.4 was recognized. Goodwill related to the Amran (U.S.) acquisition is deductible for U.S. income tax purposes; the goodwill related to the Narayan (India) acquisition isnot deductible. The accounting for business combinations requires estimates and judgments regarding expectations for future cash flows of the acquired business, and the allocations of those cash flows to identifiable tangible and intangible assets, in determining the assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's best estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. The fair value of the noncontrolling interest in Narayan was determined based on the consideration expected to be transferred by the Company for its controlling ownership interest based on the Standex share price at the Closing Date.

11

The following table summarizes the allocation of the aggregate total consideration for the Amran/Narayan Group to the estimated fair values of the tangible and identifiable intangible assets acquired and liabilities and noncontrolling interest assumed (in thousands):

Fair value of business combination:
Total cash consideration$415,604
Less: cash acquired(7,114)
Stock consideration25,953
Total$434,443
Identifiable assets acquired and liabilities assumed:
Other acquired assets$11,799
Accounts receivable25,863
Inventories13,677
Customer backlog10,100
Property, plant, and equipment2,816
Identifiable intangible assets136,000
Goodwill298,383
Deferred tax liabilities, net(19,990)
Other liabilities assumed(17,471)
Total identifiable assets acquired and liabilities assumed461,177
Redeemable noncontrolling interest (see Note 18)(26,734)
Total identifiable assets, liabilities and redeemable noncontrolling interest$434,443

The following table reflects the unaudited pro forma operating results of the Company for thethree andsix months ended* December 31, 2024,which give effect to the acquisition of the Amran/Narayan Group as if it had occurred effective July 1, 2023.The pro forma results arenot* necessarily indicative of the operating results that would have occurred had the acquisition been effective as of the date indicated, nor are they intended to be indicative of results that* mayoccur in the future. The pro forma information doesnot* include the effects of any synergies related to the Amran/Narayan Group acquisition, transactions between the entities prior to acquisition, or the pre-acquisition impact of other businesses acquired by the Company during this period as they werenot material to the Company’s historical results of operations.

Three Months EndedSix Months Ended
(in thousands)December 31, 2024
Net sales$199,035$396,721
Net income16,22043,943

Pro forma earnings during the periods presented were adjusted to include the following adjustments:

●Amortization of inventory step-up to fair value assuming inventory turns within a two-month period;
●Amortization of definite-lived intangible assets recognized at fair value that exceed one year as if acquired July 1, 2023;
●Non-recurring acquisition-related costs have been excluded from net income;
●Interest expense (including amortization of loan discount) on the Term Loan Credit Agreement entered into in connection with the acquisition as if the loan was obtained July 1, 2023. The interest rate assumed for purposes of the pro forma financial information was 7.7% on average as the rate in agreement is a variable rate plus certain margins; and
●Income tax expense (benefit) was adjusted related to the above pro forma adjustments using an estimated tax rate of 22.6%.

12

With respect to each of the McStarlite and Amran/Narayan Group acquisitions, the estimated fair values of the indefinite lived tradenames were determined based on an income approach using the relief from royalty method, which assumes that, in lieu of ownership, athird party would be willing to pay a royalty in order to exploit the related benefits of the tradenames assets. The cash flow projections the Company uses to estimate the fair value of the tradenames intangible assets involve several assumptions, including projected revenue growth, an estimated royalty rate, after-tax royalty savings expected from ownership of the tradenames, and a discount rate used to derive the estimated fair value of the tradenames. The estimated fair value of the customer relationships intangible assets were determined based on the income approach using the multi-period excess earnings method, which measures the economic benefit indirectly by calculating the income attributable to an asset after appropriate returns are paid to complementary assets used in conjunction with the subject asset to produce the earnings associated with the subject asset, commonly referred to as contributory asset charges. The fair value determination of the customer relationships intangible asset required the Company to make significant estimates and assumptions related to future cash flows and the selection of an appropriate discount rate to apply to future cash flows.

Acquisition Related Costs

Acquisition related costs include costs related to acquired businesses and other pending acquisitions. These costs consist of (i) deferred compensation arrangements and (ii) acquisition related professional service fees and expenses, including financial advisory, legal, accounting, and other outside services incurred in connection with integration and acquisition activities, and regulatory matters related to acquired entities. These costs donot include purchase accounting expenses, which the Company defines as acquired backlog and the step-up of inventory to fair value, or the amortization of the acquired intangible assets.

Acquisition related costs for thethree months ended* December 31, 2025* and2024 were $0.6 million and $16.4 million, respectively. Acquisition related costs for thesix months ended* December 31, 2025and2024* were $1.0 million and $18.2 million, respectively.

3) Revenue From Contracts With Customers

Most of the Company’s contracts have a single performance obligation which represents the product or service being sold to the customer. Some contracts include multiple performance obligations such as a product and the related installation and/or extended warranty. Additionally, most of the Company’s contracts offer assurance type warranties in connection with the sale of a product to customers. Assurance type warranties provide a customer with assurance that the product complies with agreed-upon specifications. Assurance type warranties donot represent a separate performance obligation.

In general, the Company recognizes revenue at the point in time control transfers to its customer based on predetermined shipping terms. Revenue is recognized over time under certain long-term contracts within the Engineering Technologies and Engraving segments for highly customized customer products that haveno alternative use and in which the contract specifies the Company has a right to payment for its costs, plus a reasonable margin. For these products, the transfer of control is measured pro rata, based upon current estimates of costs to complete such contracts. Losses on contracts are fully recognized in the period in which the losses become determinable. Revisions in profit estimates are reflected on a cumulative basis in the period in which the basis for such revision becomes known.

Disaggregation of Revenue from Contracts with Customers

The following table presents revenue from continuing operations disaggregated by product line and segment (in thousands):

Three Months EndedSix Months Ended
Revenue by Product LineDecember 31, 2025December 31, 2024December 31, 2025December 31, 2024
Electronics$115,668$95,923$226,220$173,656
Engineering Technologies30,63622,64960,53043,179
Scientific19,50218,47738,95236,170
Engraving Services32,99028,84465,61158,664
Engraving Products2,7382,6105,9576,153
Total Engraving35,72831,45471,56864,817
Hydraulics Cylinders and Systems11,39312,06723,56623,689
Merchandising & Display8,3939,24417,91518,767
Total Specialty Solutions19,78621,31141,48142,456
Total revenue by product line$221,320$189,814$438,751$360,278

The following table presents revenue from continuing operations disaggregated by geography based on the Company’s locations (in thousands):

Three Months EndedThree Months EndedSix Months EndedSix Months Ended
Net salesDecember 31, 2025December 31, 2024December 31, 2025December 31, 2024
United States$128,646$111,532$254,976$212,268
Asia Pacific58,33849,706114,72187,401
EMEA (1)32,03326,36864,66755,638
Other Americas2,3032,2084,3874,971
Total$221,320$189,814$438,751$360,278

(1) EMEA consists primarily of Europe, Middle East and S. Africa.

13

The following table presents revenue from continuing operations disaggregated by timing of recognition (in thousands):

Three Months EndedSix Months Ended
Timing of Revenue RecognitionDecember 31, 2025December 31, 2024December 31, 2025December 31, 2024
Products and services transferred at a point in time$200,084$169,034$397,064$321,721
Products transferred over time21,23620,78041,68738,557
Net sales$221,320$189,814$438,751$360,278

Contract Balances

Contract assets represent revenue recognized related to work completed butnot yet billed as of the reporting date. Contract liabilities are customer deposits for which revenue hasnot been recognized. Current contract liabilities are recorded as accrued liabilities.

The timing of revenue recognition, invoicing and cash collections results in billed receivables, contract assets and contract liabilities on the consolidated balance sheets. When consideration is received from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded. Contract liabilities are recognized as revenue after control of the goods and services are transferred to the customer and all revenue recognition criteria have been met.

The following table provides information about contract assets and liability balances (in thousands):

June 30, 2025AdditionsDeductionsDecember 31, 2025
Contract assets$59,228$41,687$38,041$62,874
Contract liabilities:
Customer deposits5,1897,7452,21410,720
June 30, 2024AdditionsDeductionsDecember 31, 2024
Contract assets$45,393$36,004$25,798$55,599
Contract liabilities:
Customer deposits1,7661,8052,3771,194

We recognized the following revenue which was included in the contract liability beginning balances (in thousands):

Three months ended
Revenue recognized in the period from: · December 31, 2025 · December 31, 2024
Amounts included in the contract liability balance at the beginning of the period$768$-
Six months ended
Revenue recognized in the period from:December 31, 2025December 31, 2024
Amounts included in the contract liability balance at the beginning of the period$768$1,766

4) Fair Value Measurements

The financial instruments shown below are presented at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or inputs arenot available, valuation models* may*be applied.

14

Assets and liabilities recorded at fair value in the consolidated balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Hierarchical levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities and the methodologies used in valuation are as follows:

Level1 – Quoted prices (unadjusted) in active markets for identical assets and liabilities. The Company’s deferred compensation plan assets consist of shares in various mutual funds (investments are participant-directed) which invest in a broad portfolio of debt and equity securities. These assets are valued based on publicly quoted market prices for the funds’ shares as of the balance sheet dates.

Level2 – Inputs, other than quoted prices in an active market, that are observable either directly or indirectly through correlation with market data. For foreign exchange forward contracts and interest rate swaps, the Company values the instruments based on the market price of instruments with similar terms, which are based on spot and forward rates as of the balance sheet dates. The Company has considered the creditworthiness of counterparties in valuing all assets and liabilities.

Level3 – Unobservable inputs based upon the Company’s best estimate of what market participants would use in pricing the asset or liability.

There wereno transfers of assets or liabilities between any levels of the fair value measurement hierarchy at* December 31, 2025* or* June 30, 2025*. The Company’s policy is to recognize transfers between levels as of the date they occur.

Cash and cash equivalents, accounts receivable, accounts payable, and debt are carried at cost, which approximates fair value.

The fair values of financial instruments were as follows (in thousands):

Total · Level 1 · Level 2 · Level 3
Assets
Marketable securities - deferred compensation plan$5,954$5,954$-$-
Liabilities
Interest rate swaps$1,689$-$1,689$-
Foreign exchange contracts1,223-1,223-
Contingent consideration (a)330--330
Total · Level 1 · Level 2 · Level 3
Assets
Marketable securities - deferred compensation plan$4,980$4,980$-$-
Debt securities3,629--3,629
Equity securities2,211--2,211
Liabilities
Foreign exchange contracts$68-$68$-
Contingent consideration (a)660--660

(a) The Company’s financial liabilities based upon Level3 inputs comprise of contingent consideration arrangement relating to its acquisition of SEPL in the event that certain financial targets are achieved during thetwo years following its acquisition in thefourth quarter of fiscal year2024. The Company has determined the fair value of the liabilities for the contingent consideration based on an evaluation of the probability and amount of any deferred compensation that has been earned to date. This fair value measurement is based on significant inputsnot observable in the market and thus represents a Level3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability associated with future payments was based on several factors, the most significant of which are typically the financial performance of the acquired business and the risk-adjusted discount rate for the fair value measurement. During thesix months ended* December 31, 2025*, the reduction in the fair value of the contingent consideration liability was a result of the Company’s payment of $0.3 million pursuant to the SEPL agreement.

The Company invested $2.0 million for equity securities of a company whose securities arenot publicly traded and where fair value isnot readily available. This was recorded as investments within other non-current assets in the consolidated balance sheets to reflect the initial fair value of the stock acquired. These investments are recorded using either the equity method of accounting or the cost minus impairment adjusted for observable price changes, depending on ownership percentage and other factors that suggest significant influence. The Company concluded it doesnot have a significant ownership percentage or influence. The Company monitors these investments to evaluate whether any increase or decline in the value has occurred, based on the implied value of recent company financings, public market prices of comparable companies and general market conditions.

The Company also purchased $2.7 million of debt securities from the same privately held company. The available for sale asset was recorded in the prepaid expenses and other current assets line of the consolidated balance sheet to reflect the initial fair value of the instrument acquired. The maturity date of this asset, which was originally due to matureone year from the date of issuance, has been extended to the end of* February 2026.*

15

The Company updates its assumptions each reporting period based on new developments and records such amounts at fair value based on the revised assumptions.

5) Inventories

Inventories are comprised of the following (in thousands):

December 31, 2025June 30, 2025
Raw materials$65,922$57,302
Work in process23,00434,298
Finished goods42,27038,394
Total$131,196$129,994

Distribution costs associated with the sale of inventory, which are recorded as a component of selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations were $3.2 million and $2.5 million for thethree months ended* December 31, 2025* and2024, respectively. Distribution costs were $6.8 million and $4.9 million for thesix months ended* December 31, 2025and2024*, respectively.

6) Goodwill

Changes to goodwill by reportable segment during the period were as follows (in thousands):

June 30, 2025 · Acquisitions · Translation Adjustment · December 31, 2025
Electronics$459,051$-$(17,014)$442,037
Engineering Technologies53,778(554)(181)53,043
Scientific15,454--15,454
Engraving78,996-1,49180,487
Specialty Solutions3,059--3,059
Total$610,338$(554)$(15,704)$594,080

7) Warranty Reserves

The expected cost associated with warranty obligations on our products is recorded as a component of cost of sales when the revenue is recognized. The Company’s estimate of warranty cost is based on contract terms and historical warranty loss experience that is periodically adjusted for recent actual experience. Since warranty estimates are forecasts based on the best available information, claims costs* may*differ from amounts provided. Adjustments to initial obligations for warranties are made as changes in the obligations become reasonable to estimate.

The change in warranty reserves, which are recorded as a component of accrued liabilities were as follows (in thousands):

December 31, 2025June 30, 2025
Balance at beginning of year$2,429$2,209
Acquisitions and other charges(48)181
Warranty expense1,230705
Warranty claims(707)(666)
Balance at end of period$2,904$2,429

**8)**Debt

Long-term debt is comprised of the following (in thousands):

December 31, 2025June 30, 2025
Bank credit agreement$535,203$553,203
Total funded debt535,203553,203
Unamortized issuance costs(470)(688)
Total long-term debt$534,733$552,515

16

The Company's bank credit agreement matures in* February**2028.*

At* December 31, 2025*, and* June 30, 2025*, the Company had $3.5 million and $1.9 million standby letters of credit outstanding, primarily for insurance purposes and had the ability to borrow $212.6 million and $207.7 million under the Facility. Funds borrowed under the Facility* maybe used for the repayment of debt, working capital, capital expenditures, acquisitions (so long as certain conditions, including a specified funded debt to EBITDA leverage ratio, are maintained), and other general corporate purposes. The Facility contains customary representations, warranties and restrictive covenants, as well as specific financial covenants which the Company was compliant with as of December 31, 2025* and* June 30, 2025*.

9) Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

December 31, 2025June 30, 2025
Payroll and employee benefits$20,087$24,804
Operating lease current liability12,74111,129
Restructuring costs2,3121,457
Accrued taxes payable3,4552,662
Accrued interest3,0373,152
Professional fees2,6512,304
Warranty reserves2,9042,429
Workers' compensation1,7101,245
Contingent consideration330330
Other20,17613,692
Total$69,403$63,204

10)** **Derivative Financial Instruments

Information about the Company’s derivative financial instruments is as follows:

Interest Rate Swaps

From time to time as dictated by market opportunities, the Company enters into interest rate swap agreements designed to manage exposure to interest rates on the Company’s variable rate indebtedness. The Company recognizes all derivatives on its consolidated balance sheets at fair value. The Company designates its interest rate swap agreements, including those that* may*be forward-dated, as cash flow hedges, and changes in the fair value of the swaps are recognized in accumulated other comprehensive income until the hedged items are recognized in earnings. Hedge ineffectiveness, if any, associated with the swaps is reported in earnings within interest expense.

The Company’s effective swap agreements convert the base borrowing rate on $225 million of debt due under our Facility from a variable rate equal to1 month Secured Overnight Financing Rate (SOFR) to a weighted average fixed rate of 3.48% at* December 31, 2025*. The fair value of the swaps, recognized in accumulated other comprehensive loss, is as follows (in thousands, except percentages):

Effective Date · Notional Amount · Fixed Interest Rate · Maturity · December 31, 2025 · June 30, 2025
August 30, 2025$225,0003.48%August 30, 2028$(1,223)$-

The Company reportedno losses for thethree andsix months ended* December 31, 2025*, as a result of hedge ineffectiveness. Future changes in these swap arrangements, including termination of the agreements,* may*result in a reclassification of any gain or loss reported in accumulated other comprehensive loss into earnings as an adjustment to interest expense. Accumulated other comprehensive loss related to these instruments is being amortized into interest expense concurrent with the hedged exposure.

17

Foreign Exchange Contracts

Forward foreign currency exchange contracts are used to limit the impact of currency fluctuations on certain anticipated foreign cash flows, such as collections from customers and loan payments between subsidiaries. The Company enters into such contracts for hedging purposes only. At* December 31, 2025* and* June 30, 2025*, the Company had the following outstanding forward contract related to hedge of intercompany loans. The contract matures in* January 2026.*

The notional amounts of the Company’s forward contracts are as follows (in thousands):

CurrencyDecember 31, 2025June 30, 2025
JPY$3,650,000$3,250,000

The table below presents the fair value of derivative financial instruments as well as their classification on the balance sheet (in thousands):

Liability Derivatives
December 31, 2025 · June 30, 2025
Derivative · Balance Sheet Line Item · Fair Value · Balance Sheet Line Item · Fair Value
Interest rate swapsAccrued liabilities$1,223$-
Foreign exchange contractsAccrued liabilities1,689Accrued liabilities68
$2,912$68

The table below presents the amount reclassified from accumulated other comprehensive loss to net income for the periods ended (in thousands):

Details about Accumulated Other · Three Months Ended · Six Months Ended · Affected line item in the Unaudited
Comprehensive Loss ComponentsDecember 31, 2025December 31, 2024December 31, 2025December 31, 2024Condensed Statements of Operations
Interest rate swaps$(298)$(1,454)$(453)$(3,151)Interest expense

11) Retirement Benefits

The Company has defined benefit pension plans covering certain current and former employees both inside and outside of the U.S. The Company’s pension plan for U.S. employees is frozen for substantially all participants and has been replaced with a defined contribution benefit plan.

Net periodic benefit cost for the Company’s U.S. and foreign pension benefit plans for the periods ended consisted of the following components (in thousands):

U.S. Plans · Non-U.S. Plans
Three Months Ended December 31, · Three Months Ended December 31,
2025 · 2024 · 2025 · 2024
Service cost$-$-$56$62
Interest cost2,2882,386311302
Expected return on plan assets(2,521)(2,641)(300)(343)
Recognized net actuarial loss1,1751,055--
Amortization of prior service cost--(1)(1)
Net periodic (benefit) cost$942$800$66$20
U.S. Plans · Non-U.S. Plans
Six Months Ended December 31, · Six Months Ended December 31,
2025 · 2024 · 2025 · 2024
Service cost$-$-$114$125
Interest cost4,5774,772626608
Expected return on plan assets(5,041)(5,282)(604)(690)
Recognized net actuarial loss2,3492,111--
Amortization of prior service cost--(2)(2)
Net periodic (benefit) cost$1,885$1,601$134$41

18

The following table sets forth the amounts recognized for the Company's defined benefit pension plans (in thousands):

Amounts recognized in the consolidated balance sheets consist of:December 31, 2025June 30, 2025
Prepaid benefit cost$3,322$3,294
Current liabilities(1,258)(589)
Non-current liabilities(30,957)(31,721)
Net amount recognized$(28,893)$(29,016)

The contributions made to defined benefit plans are presented below along with remaining contributions to be made for the current fiscal year (in thousands):

Three Months Ended · Six Months Ended
Contributions to defined benefit plansDecember 31, 2025December 31, 2025Remaining Contributions
United States, funded plan$1,483$2,742$3,807
United States, unfunded plan285462
Germany, unfunded plan--275
$1,511$2,796$4,144

12**) Income Taxes**

The Company's effective tax rate from continuing operations for thethree andsix months ended* December 31, 2025* was 24.1% and 24.3%, respectively, compared with 35.5% and 22.6% for the equivalent prior year periods, respectively.

The tax rate was impacted in thethree andsix months ended* December 31, 2025* by the following items: (i) changes in the geographic mix of earnings; (ii) the recognition of a discrete tax benefit related to equity compensation; (iii) foreign withholding taxes; and (iv) federal tax credits related to research and development activities. The tax rate was impacted in thethree andsix months ended* December 31, 2024* by the following items: (i) a discrete tax benefit related to equity compensation, (ii) a discrete tax expense related to the write-off of foreign deferred tax assets, (iii) the jurisdictional mix of earnings, (iv) foreign withholding taxes; and (v) federal research and development tax credits.

**13)**Earnings Per Share

The Company uses shares acquired through treasury stock repurchases for the issuance of shares of common stock for the settlement of awards under its stock-based compensation plans, with the net effect of these transactions accounting for the change in common stock outstanding.

The following table sets forth a reconciliation of the number of shares (in thousands) used in the computation of basic and diluted earnings per share:

Three Months Ended December 31,Six Months Ended December 31,
2025202420252024
Basic - Average shares outstanding12,04311,94212,02711,872
Dilutive effect of unvested, restricted stock awards128346100
Diluted - Average shares outstanding12,05512,02512,07311,972

Earnings available to common stockholders are the same for computing both basic and diluted earnings per share. There wereno outstanding instruments that had an anti-dilutive effect at* December 31, 2025* or2024.

Performance stock units of 62,558 and 111,830 for thethree andsix months ended* December 31, 2025* and2024, respectively, are excluded from the diluted earnings per share calculation as the performance criteria havenot been met.

14**)**** Accumulated OtherComprehensiveL****oss**

The components of the Company’s accumulated other comprehensive loss are as follows (in thousands):

December 31, 2025June 30, 2025
Foreign currency translation adjustment$(98,962)$(74,788)
Unrealized pension losses, net of tax(89,118)(90,972)
Unrealized gains on derivative instruments, net of tax61995
Total$(188,019)$(164,765)

15**) Contingencies**

From time to time, the Company is subject to various claims and legal proceedings, including claims related to environmental remediation, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of these proceedings and claims cannot be predicted with certainty, the Company’s management doesnot believe that the outcome of any of the currently existing legal matters will have a material impact on the Company’s consolidated financial position, results of operations or cash flow. The Company accrues for losses related to a claim or litigation when the Company’s management considers a potential loss probable and can reasonably estimate such potential loss.

19

16) Industry Segment Information

The Company hasfive reportable segments organized around the types of products sold:

•Electronics – manufactures and sells electronic components for applications throughout the end user market spectrum;
•Engineering Technologies – provides net and near net formed single-source customized solutions in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets;
•Scientific – sells specialty temperature-controlled equipment for the medical, scientific, pharmaceutical, biotech and industrial markets;
•Engraving - provides mold texturing, slush molding tools, project management and design services, roll engraving, hygiene product tooling, low observation vents for stealth aircraft, and process machinery for a number of industries;
•Specialty Solutions – an aggregation of two operating segments that manufacture and sell refrigerated, heated and dry merchandizing display cases and single and double acting telescopic and piston rod hydraulic cylinders.

Net sales and income from continuing operations by segment were as follows (in thousands):

ElectronicsEngineering TechnologiesScientificEngravingSpecialty SolutionsTotal
Net Sales$115,668$30,636$19,502$35,728$19,786$221,320
Segment Expenses(85,903)(26,259)(15,014)(29,160)(17,674)(174,010)
Segment operating income29,7654,3774,4886,5682,11247,310
Corporate(10,682)
Restructuring costs(438)
Acquisition related costs(617)
Income From Operations35,573
Interest expense(7,914)
Other non-operating expense, net(490)
Income from continuing operations before income taxes$27,169
ElectronicsEngineering TechnologiesScientificEngravingSpecialty SolutionsTotal
Net Sales$226,220$60,530$38,952$71,568$41,481$438,751
Segment Expenses(168,172)(52,536)(29,785)(58,464)(36,481)(345,438)
Segment operating income58,0487,9949,16713,1045,00093,313
Corporate(20,622)
Restructuring costs(6,436)
Acquisition related costs(1,049)
Income From Operations65,206
Interest expense(16,826)
Other non-operating expense income, net(225)
Income from continuing operations before income taxes$48,155
ElectronicsEngineering TechnologiesScientificEngravingSpecialty SolutionsTotal
Net Sales$95,923$22,649$18,477$31,454$21,311$189,814
Segment Expenses(78,504)(18,957)(13,759)(27,332)(17,749)(156,301)
Segment operating income17,4193,6924,7184,1223,56233,513
Corporate(7,730)
Restructuring costs(920)
Acquisition related costs(16,400)
Income From Operations8,463
Interest expense5,575
Other non-operating expense, net890
Income from continuing operations before income taxes$1,998

20

ElectronicsEngineering TechnologiesScientificEngravingSpecialty SolutionsTotal
Net Sales$173,656$43,179$36,170$64,817$42,456$360,278
Segment Expenses(139,209)(35,477)(26,703)(54,871)(35,346)(291,606)
Segment operating income34,4477,7029,4679,9467,11068,672
Corporate(15,864)
Restructuring costs(2,006)
Acquisition related costs(18,240)
Income From Operations32,562
Interest expense6,552
Other non-operating expense, net862
Income from continuing operations before income taxes$25,148

Capital expenditures and depreciation and amortization expense by segment were as follows (in thousands):

Capital ExpendituresDepreciation and Amortization
Three Months Ended December 31, 2025Three Months Ended December 31, 2024Three Months Ended December 31, 2025Three Months Ended December 31, 2024
Electronics$4,079$2,248$5,806$4,957
Engineering Technologies7611,4291,549897
Scientific180474318311
Engraving7701,4831,7781,916
Specialty Solutions1,8681,095420363
Corporate and Other623611361
Total$7,664$6,965$9,984$8,505
Capital ExpendituresDepreciation and Amortization
Six Months Ended December 31, 2025Six Months Ended December 31, 2024Six Months Ended December 31, 2025Six Months Ended December 31, 2024
Electronics$7,747$5,799$11,591$8,371
Engineering Technologies2,3462,8922,9571,783
Scientific251543638630
Engraving1,3422,4243,5663,945
Specialty Solutions2,3241,538842714
Corporate and Other74494207123
Total$14,084$13,690$19,801$15,566

Net sales include only transactions with unaffiliated customers and includeno intersegment sales. Income from operations by segment excludes interest expense and other non-operating (income) expense.

17) Restructuring

The Company has undertaken a number of initiatives that have resulted in severance, restructuring, and related charges. Related charges* mayincludethird* party assistance with analysis and implementation of these activities.

21

2026 Restructuring Initiatives

The Company continues to focus its efforts to reduce cost and improve productivity across its businesses. Restructuring expenses primarily related to facility rationalizations and consolidations. The Company expects the2026 restructuring activities to be completed by fiscal year2027.

Prior Year Restructuring Initiatives

Restructuring expenses primarily related to headcount reductions and other cost saving initiatives within our Engraving and Electronics segments. The Company expects the prior year restructuring activities to be completed by fiscal year2026.

A summary of charges by initiative is as follows (in thousands):

Three Months Ended December 31, 2025Six Months Ended December 31, 2025
Fiscal Year 2026Involuntary Employee Severance and Benefit CostsOtherTotalInvoluntary Employee Severance and Benefit CostsOtherTotal
Current year initiatives$197$51$248$4,798$133$4,931
Prior year initiatives15175$190861644$1,505
$212$226$438$5,659$777$6,436
Three Months Ended December 31, 2024Six Months Ended December 31, 2024
Fiscal Year 2025Involuntary Employee Severance and Benefit CostsOtherTotalInvoluntary Employee Severance and Benefit CostsOtherTotal
Current year initiatives$515$92$607$780$258$1,038
Prior year initiatives80233313424544968
$595$325$920$1,204$802$2,006

Activity in the restructuring liability reserve related to the initiatives is as follows (in thousands):

Current Year InitiativesInvoluntary Employee Severance and Benefit CostsOtherTotal
Restructuring liabilities at June 30, 2025 · $ · - · $ · - · $ · -
Additions and adjustments4,7981334,931
Payments(2,881)-(2,881)
Restructuring liabilities at December 31, 2025$1,917$133$2,050
Prior Year Initiatives · Involuntary Employee Severance and Benefit Costs · Other · Total
Restructuring liabilities at June 30, 2025$1,397$60$1,457
Additions and adjustments8616441,505
Payments(1,996)(704)(2,700)
Restructuring liabilities at December 31, 2025$262$-$262

22

Prior YearInvoluntary Employee Severance and Benefit CostsOtherTotal
Restructuring liabilities at June 30, 2024$1,253$194$1,447
Additions and adjustments423545968
Payments(1,261)(603)(1,864)
Restructuring liabilities at December 31, 2024$415$136$551

The Company’s total restructuring expenses by segment are as follows:

Three Months Ended December 31, 2025 · Six Months Ended December 31, 2025
Involuntary Employee Severance and Benefit Costs · Other · Total · Involuntary Employee Severance and Benefit Costs · Other · Total
Electronics$-$90$90$426$389$815
Engineering Technologies19-1919-19
Engraving1931363295,1433885,531
Specialty Solutions---71-71
$212$226$438$5,659$777$6,436
Three Months Ended December 31, 2024 · Six Months Ended December 31, 2024
Involuntary Employee Severance and Benefit Costs · Other · Total · Involuntary Employee Severance and Benefit Costs · Other · Total
Engraving$498$325$8231,0288021,830
Electronics$97$-9797-97
Corporate---79-79
$595$325$920$1,204$802$2,006

Restructuring expense is expected to be approximately $1.0 million for the remainder of fiscal year2026.

18) Redeemable Noncontrolling Interest

The redeemable noncontrolling interest consists of 9.9% of common stock of Narayan Powertech Private Limited ("Narayan"), a privately-held India-based company. The Company owns the remaining 90.1%. During thethree andsix months ended* December 31, 2025*, Narayan declared and distributed a dividend of $0.9 million and $1.6 million, respectively, to the Company and its noncontrolling interests, allocated according to equity ownership.

In accounting for the subsequent measurement of the redeemable noncontrolling interest measurement adjustments pursuant to ASC480, Distinguishing Liabilities from Equity, the Company has made accounting policy elections to record any such applicable changes on the immediate recognition of the full adjustment required to report the redeemable noncontrolling interest at its redemption value, while also electing to record such adjustments under the income method, with a corresponding offset recorded to the Net income attributable to noncontrolling interests in consolidated subsidiaries within the consolidated statement of operations for the period in which such measurement adjustment becomes required. Given the lack of approval from RBI for thesecond closing and share swap, part of the noncontrolling interest is currently redeemable and the remaining noncontrolling interest is probable of redemption as of* December 31, 2025*. A re-measurement adjustment of $18 million has been recorded for thethree andsix months ended* December 31, 2025* to record the non-controlling interest as of* December 31, 2025*at its estimated redemption value based on the terms of the agreement with the non-controlling interest shareholder. This re-measurement adjustment has been recorded as a component of the total net income attributable to redeemable noncontrolling interest financial statement line in the Company’s condensed consolidated statements of operations.

23

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.